{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:52:01Z","timestamp":1790488321051,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005612","name":"Shionogi & Co. Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijid.2019.08.008","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T11:39:57Z","timestamp":1565696397000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-4554","authenticated-orcid":false,"given":"Kentaro","family":"Nagaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasumi","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijid.2019.08.008_bib0005","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.008_bib0010","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","article-title":"Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis","volume":"162","author":"Arancibia","year":"2002","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.008_bib0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/338197","article-title":"Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa","volume":"185","author":"Banwart","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.008_bib0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-8518-1-2","article-title":"Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model","volume":"1","author":"Faure","year":"2003","journal-title":"J Immune Based Ther Vaccines"},{"issue":"11","key":"10.1016\/j.ijid.2019.08.008_bib0025","first-page":"1602","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.ijid.2019.08.008_bib0030","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/CCM.0b013e31825334f6","article-title":"Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial","volume":"40","author":"Fran\u00e7ois","year":"2012","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.008_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.83.1.63","article-title":"Diffuse panbronchiolitis. A disease of the transitional zone of the lung","volume":"83","author":"Homma","year":"1983","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.008_bib0040","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1183\/09031936.00147406","article-title":"Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model","volume":"29","author":"Imamura","year":"2007","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.008_bib0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcf.2017.12.006","article-title":"KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa","volume":"17","author":"Jain","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ijid.2019.08.008_bib0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.resinv.2014.09.004","article-title":"An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasis","volume":"53","author":"Kadowaki","year":"2015","journal-title":"Respir Investig"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.008_bib0055","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2019.08.008_bib0060","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","article-title":"Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa","volume":"42","author":"Kollef","year":"2014","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.008_bib0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.293.5.581","article-title":"Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis","volume":"293","author":"Li","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2019.08.008_bib0070","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious diseases society of America\/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44 Suppl 2","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2019.08.008_bib0075","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2019.08.008_bib0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-015-0926-5","article-title":"An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance","volume":"19","author":"Micek","year":"2015","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.008_bib0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ppul.21022","article-title":"Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis","volume":"44","author":"Milagres","year":"2009","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.008_bib0090","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/IAI.69.2.1185-1188.2001","article-title":"Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus","volume":"69","author":"Moss","year":"2001","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.ijid.2019.08.008_bib0095","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.008_bib0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MCP.0b013e328321861a","article-title":"Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease","volume":"15","author":"Murphy","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.ijid.2019.08.008_bib0105","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2147\/COPD.S140901","article-title":"Bacteriological incidence in pneumonia patients with pulmonary emphysema: a bacterial floral analysis using the 16S ribosomal RNA gene in bronchoalveolar lavage fluid","volume":"12","author":"Naito","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.008_bib0110","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1183\/09031936.06.00131805","article-title":"Diffuse panbronchiolitis","volume":"28","author":"Poletti","year":"2006","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ijid.2019.08.008_bib0115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s13054-014-0668-9","article-title":"Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review","volume":"18","author":"Sawa","year":"2014","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.008_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/7391","article-title":"Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ijid.2019.08.008_bib0125","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4049\/jimmunol.167.10.5880","article-title":"Therapeutic administration of anti-PcrV F(ab\u2019)(2) in sepsis associated with Pseudomonas aeruginosa","volume":"167","author":"Shime","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2019.08.008_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.05.001","article-title":"Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis","volume":"128","author":"Suarez-Cuartin","year":"2017","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ijid.2019.08.008_bib0135","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/infdis\/jiv436","article-title":"Pseudomonas aeruginosa bacteremic patients exhibit nonprotective antibody titers against therapeutic antibody targets PcrV and Psl exopolysaccharide","volume":"213","author":"Thaden","year":"2016","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ijid.2019.08.008_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168164","article-title":"Clinical features and outcomes of IPF patients hospitalized for pulmonary infection: a Japanese cohort study","volume":"11","author":"Yamazaki","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijid.2019.08.008_bib0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/1348-0421.12353","article-title":"Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults","volume":"60","author":"Yasumoto","year":"2016","journal-title":"Microbiol Immunol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219303340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219303340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T10:41:47Z","timestamp":1570617707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219303340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":29,"alternative-id":["S1201971219303340"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.08.008","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-PcrV titers in non-cystic fibrosis patients with Pseudomonas aeruginosa respiratory tract infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}